Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-4-30
|
pubmed:abstractText |
Using the protein A plaque assay, the capacity of various polyclonal B cell activators to induce differentiation in human B lymphocytes was investigated. Dextran sulphate and native dextran were both virtually devoid of mitogenic properties. Lipopolysaccharide, however, was found to be a potent mitogen in human cells that, although giving rise to low DNA synthetic response, induced high numbers of immunoglobulin-synthesizing cells. Mean plaque-forming cell (PFC) numbers in healthy blood donors assayed on the optimal day (days 5-7) were 23,493 IgM/10(6) cells, 11,288 IgG/10(6) cells, and 2643 IgA/10(6) cells. Values obtained in spleen cells, peaking at days 4-6, were slightly higher. Purified protein derivative (PPD) was equally or even more effective than lipopolysaccharide (LPS) in generating PFC of different subclasses in peripheral blood with mean of 29,241 IgM/10(6), 21,269 IgG/10(6), and 3681 IgA/10(6). PPD furthermore induced a marked DNA synthetic response in human lymphocytes. These data suggest that LPS and PPD may both be used as functional markers in human cells when analysing patients with a suspected immunodeficiency state. It is suggested that cultures should be assayed using the protein A plaque assay, thereby being able not only to investigate the individual immunoglobulin classes but also to avoid the possible hazards involved in measuring antigen-specific responses in patients whose prior immunization to the antigen tested can never be totally excluded.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Dextran Sulfate,
http://linkedlifedata.com/resource/pubmed/chemical/Dextrans,
http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Tuberculin
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-9475
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-13
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9537023-B-Lymphocytes,
pubmed-meshheading:9537023-Cell Differentiation,
pubmed-meshheading:9537023-Cells, Cultured,
pubmed-meshheading:9537023-DNA,
pubmed-meshheading:9537023-Dextran Sulfate,
pubmed-meshheading:9537023-Dextrans,
pubmed-meshheading:9537023-Humans,
pubmed-meshheading:9537023-Immunologic Techniques,
pubmed-meshheading:9537023-Kinetics,
pubmed-meshheading:9537023-Lipopolysaccharides,
pubmed-meshheading:9537023-Lymphocyte Activation,
pubmed-meshheading:9537023-Tuberculin,
pubmed-meshheading:9537023-Viral Plaque Assay
|
pubmed:year |
1980
|
pubmed:articleTitle |
Mitogenic activation of human lymphocytes: a protein A plaque assay evaluation of polyclonal B-cell activators.
|
pubmed:affiliation |
Department of Immunobiology, Karolinska Institute, Wallenberglaboratory, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|